We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Quantitative Molecular Test Improves Diagnosis of Brucellosis

By LabMedica International staff writers
Posted on 02 Nov 2011
Rapid diagnosis of individuals infected with brucellosis can sometimes be difficult with conventional microbiological techniques.

The diagnostic yield of a real-time polymerase chain reaction (rt-PCR) assay during an outbreak of brucellosis supported the rapid identification of the causative organism. More...


Microbiologists at the Carlos Haya University Hospital (Malaga, Spain) compared the rt-PCR with conventional microbiological methods for diagnosing brucellosis in a family outbreak of brucellosis due to consumption of unpasteurized goat cheese. Two blood culture sets, a quantitative rt- PCR assay in serum, Rose Bengal test, standard agglutination test (SAT), and immunocapture–agglutination test were performed for all the patients with suspected Brucella infection. In patients exposed but asymptomatic, only serology and real-time PCR were performed.

Blood cultures were positive in three of the eight symptomatic cases and all of them identified as Brucella melitensis biovar 3. The Rose Bengal test result was positive in seven of the symptomatic subjects. SAT and the immunocapture-agglutination test result had titers within the diagnostic range for six patients. SAT and the immunocapture–agglutination test results were positive but showed titers below the diagnostic range in the remaining two cases and in both asymptomatic subjects.

The PCR amplifications were performed in capillary tubes with a LightCycler instrument (Roche Diagnostic; San Cugat del Valles, Spain) using primers obtained from Tib-Molbiol (Berlin, Germany). Each assay was performed using a standard curve of genomic B. melitensis DNA (2 × 105 genome copies per 2 mL DNA extract) and negative controls (water). The rt-PCR was positive in all subjects who became ill and negative in those who did not develop symptoms.

The authors concluded that quantitative rt-PCR could be a useful tool for the rapid diagnosis of persons involved in outbreaks of brucellosis due to occasional consumption of unpasteurized milk or cheese. However, it is possible that this technology will have no practical use for handling outbreaks in occupationally exposed subjects, and studies are needed to determine its usefulness in outbreaks affecting laboratory workers. The study was published in the November 2011 edition of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Carlos Haya University Hospital
Roche Diagnostic
Tib-Molbiol




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.